Pharvaris N.V.

PHVS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001830487

SEC filings (opens in a new tab)

In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.

Q4 2025 vs. Q3 2025

How the institutions holding Pharvaris N.V. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of PHVS: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	83	2	106	+25
Shares	57.8M	11.6K	59.0M	+1.21M (+2.1%)
Value	$1.44B	$290.4K	$1.64B	+$195.2M (+13.5%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Pharvaris N.V. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to PHVS in Q4 2025
Institution	Shares	Value	% of portfolio
Elmind Capital, LP	475,750	$13.2M	3.90%
Eversept Partners, LP	439,177	$12.2M	0.68%
OrbiMed Advisors LLC	205,400	$5.70M	0.12%
Kalehua Capital Management LLC	198,772	$5.52M	5.46%
HighVista Strategies LLC	162,370	$4.51M	1.16%
Squarepoint Ops LLC	100,359	$2.78M	0.01%
Two Sigma Advisers, LP	89,600	$2.49M	0.00%
Trexquant Investment LP	84,353	$2.34M	0.02%
UBS Asset Management Americas Inc	83,947	$2.33M	0.00%
Susquehanna International Group, LLP	61,624	$1.71M	0.00%
StemPoint Capital LP	58,389	$1.62M	0.28%
Seven Fleet Capital Management LP	55,342	$1.54M	1.04%
Alps Advisors Inc	52,592	$1.46M	0.01%
Quadrature Capital Ltd	28,920	$802.5K	0.01%
Jump Financial, LLC	26,300	$729.8K	0.01%
SummitTX Capital, L.P.	22,859	$634.3K	0.02%
PSP Research LLC	20,511	$569.2K	0.50%
Verition Fund Management LLC	17,898	$496.7K	0.00%
Qube Research & Technologies Ltd	14,706	$408.1K	0.00%
Occudo Quantitative Strategies LP	12,349	$342.7K	0.02%
Teacher Retirement System of Texas	8,911	$247.3K	0.00%
Nano Cap New Millennium Growth Fund L P	5,000	$138.8K	0.12%
Quantbot Technologies LP	4,260	$118.2K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	3,979	$110.4K	0.00%
Mirae Asset Global Investments Co., Ltd.	3,113	$86.4K	0.00%
Barclays PLC	2,775	$77.0K	0.00%
GF Fund Management Co. Ltd.	1,258	$34.9K	0.00%
Tower Research Capital LLC (TRC)	471	$13.1K	0.00%
Wells Fargo & Company	450	$12.5K	0.00%
Daiwa Securities Group Inc.	213	$6.00K	0.00%
Caitong International Asset Management Co., Ltd	6	$166	0.00%

Sold out (6)

Institutions that held Pharvaris N.V. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of PHVS in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Paradigm Biocapital Advisors LP	1,835,494	$45.8M
VR Adviser, LLC	674,599	$16.8M
Integral Health Asset Management, LLC	200,000	$4.99M
Silverarc Capital Management, LLC	183,903	$4.59M
Woodline Partners LP	100,000	$2.50M
Quarry LP	442	$11.0K

Not filed for Q4 2025 yet (2)

Institutions that held Pharvaris N.V. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PHVS in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Cubist Systematic Strategies, LLC	11,639	$290.4K
Point72 Asia (Singapore) Pte. Ltd.	1	$25